ATF-5 has been reported to regulate expression of Egr-1, BCL-2, and MCL1 to mediate proliferation and survival in cancer (Dluzen et al., 2011; Liu et al., 2011; Karpel-Massler et al., 2016). Here, ATF5 is linked to cancer.